nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—prostate cancer—bone cancer	0.43	1	CtDrD
Ethinyl Estradiol—NR1I2—bone cancer	0.282	0.835	CbGaD
Ethinyl Estradiol—CYP3A4—bone cancer	0.0558	0.165	CbGaD
Ethinyl Estradiol—AOX1—Methotrexate—bone cancer	0.0429	0.243	CbGbCtD
Ethinyl Estradiol—ABCB11—Doxorubicin—bone cancer	0.0254	0.144	CbGbCtD
Ethinyl Estradiol—ABCC2—Carboplatin—bone cancer	0.0233	0.132	CbGbCtD
Ethinyl Estradiol—ABCC2—Cisplatin—bone cancer	0.0199	0.113	CbGbCtD
Ethinyl Estradiol—ABCC2—Doxorubicin—bone cancer	0.0134	0.0756	CbGbCtD
Ethinyl Estradiol—ABCC2—Methotrexate—bone cancer	0.0129	0.0732	CbGbCtD
Ethinyl Estradiol—CYP2B6—Cisplatin—bone cancer	0.0127	0.0717	CbGbCtD
Ethinyl Estradiol—CYP2B6—Doxorubicin—bone cancer	0.0085	0.0481	CbGbCtD
Ethinyl Estradiol—ABCB1—Cisplatin—bone cancer	0.0065	0.0368	CbGbCtD
Ethinyl Estradiol—ABCB1—Doxorubicin—bone cancer	0.00436	0.0246	CbGbCtD
Ethinyl Estradiol—ABCB1—Methotrexate—bone cancer	0.00422	0.0239	CbGbCtD
Ethinyl Estradiol—CYP3A4—Doxorubicin—bone cancer	0.00261	0.0148	CbGbCtD
Ethinyl Estradiol—Estradiol valerate/Dienogest—CYP3A4—bone cancer	0.00038	0.218	CrCbGaD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.000358	0.0121	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00035	0.0118	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—ZNF77—bone cancer	0.000338	0.0114	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Tryptophan metabolism—CYP3A4—bone cancer	0.000322	0.0109	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00032	0.0108	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.000315	0.0106	CbGpPWpGaD
Ethinyl Estradiol—Estradiol—NR1I2—bone cancer	0.00031	0.178	CrCbGaD
Ethinyl Estradiol—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0003	0.0101	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000299	0.0101	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Nuclear Receptors—NR1I2—bone cancer	0.000298	0.01	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000281	0.0095	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.000261	0.00881	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Ovarian Infertility Genes—CDK4—bone cancer	0.000245	0.00828	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—ZNF77—bone cancer	0.000238	0.00803	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.000235	0.00794	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000233	0.00788	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000229	0.00771	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000225	0.00758	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000214	0.00722	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000208	0.00704	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000196	0.00663	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.00019	0.00643	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000186	0.00627	CbGpPWpGaD
Ethinyl Estradiol—Embolism—Doxorubicin—bone cancer	0.000185	0.00757	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000185	0.00623	CbGpPWpGaD
Ethinyl Estradiol—Thrombosis—Epirubicin—bone cancer	0.000181	0.00742	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.00018	0.00609	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000176	0.00596	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000175	0.00591	CbGpPWpGaD
Ethinyl Estradiol—Irritability—Cisplatin—bone cancer	0.000173	0.00709	CcSEcCtD
Ethinyl Estradiol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000172	0.00581	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.00017	0.00573	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.000168	0.00566	CbGpPWpGaD
Ethinyl Estradiol—Thrombosis—Doxorubicin—bone cancer	0.000168	0.00687	CcSEcCtD
Ethinyl Estradiol—ESR1—Estrogen Receptor Pathway—JUN—bone cancer	0.000164	0.00553	CbGpPWpGaD
Ethinyl Estradiol—Breast disorder—Cisplatin—bone cancer	0.000164	0.00671	CcSEcCtD
Ethinyl Estradiol—NR1I2—Gene Expression—ZNF77—bone cancer	0.000163	0.0055	CbGpPWpGaD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—CHEK2—bone cancer	0.000158	0.00534	CbGpPWpGaD
Ethinyl Estradiol—Estramustine—CYP3A4—bone cancer	0.000158	0.0907	CrCbGaD
Ethinyl Estradiol—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000157	0.00531	CbGpPWpGaD
Ethinyl Estradiol—Etonogestrel—CYP3A4—bone cancer	0.000156	0.0894	CrCbGaD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—WT1—bone cancer	0.000155	0.00523	CbGpPWpGaD
Ethinyl Estradiol—Herpes simplex—Methotrexate—bone cancer	0.000149	0.00609	CcSEcCtD
Ethinyl Estradiol—AOX1—Tryptophan metabolism—MDM2—bone cancer	0.000148	0.005	CbGpPWpGaD
Ethinyl Estradiol—Breast pain—Epirubicin—bone cancer	0.000147	0.00602	CcSEcCtD
Ethinyl Estradiol—Amenorrhoea—Epirubicin—bone cancer	0.000146	0.00598	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000143	0.00483	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen signaling pathway—BRAF—bone cancer	0.000143	0.00481	CbGpPWpGaD
Ethinyl Estradiol—Herpes simplex—Epirubicin—bone cancer	0.000139	0.0057	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Cisplatin—bone cancer	0.000138	0.00564	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Methotrexate—bone cancer	0.000137	0.00561	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Cisplatin—bone cancer	0.000137	0.00561	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Cisplatin—bone cancer	0.000137	0.00561	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000136	0.0046	CbGpPWpGaD
Ethinyl Estradiol—Breast pain—Doxorubicin—bone cancer	0.000136	0.00557	CcSEcCtD
Ethinyl Estradiol—Amenorrhoea—Doxorubicin—bone cancer	0.000135	0.00553	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000134	0.00454	CbGpPWpGaD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—BRCA2—bone cancer	0.000134	0.00453	CbGpPWpGaD
Ethinyl Estradiol—Cystitis noninfective—Methotrexate—bone cancer	0.000134	0.00548	CcSEcCtD
Ethinyl Estradiol—Cystitis—Methotrexate—bone cancer	0.000132	0.00542	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.000132	0.00444	CbGpPWpGaD
Ethinyl Estradiol—Estropipate—CYP3A4—bone cancer	0.00013	0.0746	CrCbGaD
Ethinyl Estradiol—Vaginal infection—Methotrexate—bone cancer	0.000129	0.0053	CcSEcCtD
Ethinyl Estradiol—Herpes simplex—Doxorubicin—bone cancer	0.000129	0.00528	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Epirubicin—bone cancer	0.000128	0.00525	CcSEcCtD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.000126	0.00426	CbGpPWpGaD
Ethinyl Estradiol—Cystitis noninfective—Epirubicin—bone cancer	0.000125	0.00513	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Epirubicin—bone cancer	0.000125	0.0051	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Methotrexate—bone cancer	0.000124	0.00508	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Methotrexate—bone cancer	0.000124	0.00508	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Cisplatin—bone cancer	0.000124	0.00507	CcSEcCtD
Ethinyl Estradiol—Cystitis—Epirubicin—bone cancer	0.000124	0.00507	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Cisplatin—bone cancer	0.000123	0.00505	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Cisplatin—bone cancer	0.000123	0.00504	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Epirubicin—bone cancer	0.000122	0.00499	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Epirubicin—bone cancer	0.000121	0.00496	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Cisplatin—bone cancer	0.000121	0.00495	CcSEcCtD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—ZNF77—bone cancer	0.00012	0.00405	CbGpPWpGaD
Ethinyl Estradiol—Vaginal inflammation—Doxorubicin—bone cancer	0.000119	0.00486	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Cisplatin—bone cancer	0.000117	0.0048	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Epirubicin—bone cancer	0.000116	0.00475	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Epirubicin—bone cancer	0.000116	0.00475	CcSEcCtD
Ethinyl Estradiol—Cystitis noninfective—Doxorubicin—bone cancer	0.000116	0.00475	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Doxorubicin—bone cancer	0.000115	0.00472	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—ZNF77—bone cancer	0.000115	0.00387	CbGpPWpGaD
Ethinyl Estradiol—Cystitis—Doxorubicin—bone cancer	0.000115	0.00469	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000114	0.00386	CbGpPWpGaD
Ethinyl Estradiol—Immune system disorder—Cisplatin—bone cancer	0.000113	0.00464	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Doxorubicin—bone cancer	0.000113	0.00462	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Doxorubicin—bone cancer	0.000112	0.00459	CcSEcCtD
Ethinyl Estradiol—Alopecia—Cisplatin—bone cancer	0.000111	0.00454	CcSEcCtD
Ethinyl Estradiol—Levonorgestrel—CYP3A4—bone cancer	0.00011	0.0633	CrCbGaD
Ethinyl Estradiol—Malnutrition—Cisplatin—bone cancer	0.000109	0.00447	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Doxorubicin—bone cancer	0.000107	0.0044	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Doxorubicin—bone cancer	0.000107	0.0044	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000106	0.00358	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000106	0.00356	CbGpPWpGaD
Ethinyl Estradiol—Visual disturbance—Methotrexate—bone cancer	0.000105	0.0043	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Cisplatin—bone cancer	0.000105	0.0043	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000104	0.00351	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen signaling pathway—JUN—bone cancer	0.000104	0.0035	CbGpPWpGaD
Ethinyl Estradiol—Eczema—Epirubicin—bone cancer	0.000104	0.00424	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Methotrexate—bone cancer	0.000102	0.00416	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Cisplatin—bone cancer	0.000101	0.00415	CcSEcCtD
Ethinyl Estradiol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000101	0.00339	CbGpPWpGaD
Ethinyl Estradiol—Danazol—CYP3A4—bone cancer	0.0001	0.0576	CrCbGaD
Ethinyl Estradiol—Hot flush—Epirubicin—bone cancer	9.95e-05	0.00408	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—CDK4—bone cancer	9.95e-05	0.00336	CbGpPWpGaD
Ethinyl Estradiol—Increased appetite—Epirubicin—bone cancer	9.91e-05	0.00406	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Epirubicin—bone cancer	9.87e-05	0.00404	CcSEcCtD
Ethinyl Estradiol—Malaise—Cisplatin—bone cancer	9.84e-05	0.00403	CcSEcCtD
Ethinyl Estradiol—Eczema—Doxorubicin—bone cancer	9.58e-05	0.00393	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Epirubicin—bone cancer	9.5e-05	0.00389	CcSEcCtD
Ethinyl Estradiol—Irritability—Methotrexate—bone cancer	9.49e-05	0.00389	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.48e-05	0.0032	CbGpPWpGaD
Ethinyl Estradiol—Mood swings—Methotrexate—bone cancer	9.42e-05	0.00386	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.35e-05	0.00316	CbGpPWpGaD
Ethinyl Estradiol—Pain in extremity—Epirubicin—bone cancer	9.31e-05	0.00381	CcSEcCtD
Ethinyl Estradiol—Anxiety—Cisplatin—bone cancer	9.26e-05	0.00379	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	9.23e-05	0.00378	CcSEcCtD
Ethinyl Estradiol—Hot flush—Doxorubicin—bone cancer	9.21e-05	0.00377	CcSEcCtD
Ethinyl Estradiol—Discomfort—Cisplatin—bone cancer	9.18e-05	0.00376	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Doxorubicin—bone cancer	9.17e-05	0.00376	CcSEcCtD
Ethinyl Estradiol—Affect lability—Epirubicin—bone cancer	9.16e-05	0.00375	CcSEcCtD
Ethinyl Estradiol—Migraine—Epirubicin—bone cancer	9.16e-05	0.00375	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Doxorubicin—bone cancer	9.13e-05	0.00374	CcSEcCtD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	9.08e-05	0.00306	CbGpPWpGaD
Ethinyl Estradiol—Breast disorder—Methotrexate—bone cancer	8.99e-05	0.00368	CcSEcCtD
Ethinyl Estradiol—Norethindrone—CYP3A4—bone cancer	8.92e-05	0.0513	CrCbGaD
Ethinyl Estradiol—Oedema—Cisplatin—bone cancer	8.91e-05	0.00365	CcSEcCtD
Ethinyl Estradiol—Infection—Cisplatin—bone cancer	8.85e-05	0.00363	CcSEcCtD
Ethinyl Estradiol—Mood swings—Epirubicin—bone cancer	8.82e-05	0.00361	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Doxorubicin—bone cancer	8.79e-05	0.0036	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Cisplatin—bone cancer	8.74e-05	0.00358	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	8.66e-05	0.00292	CbGpPWpGaD
Ethinyl Estradiol—Skin disorder—Cisplatin—bone cancer	8.65e-05	0.00355	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—RB1—bone cancer	8.65e-05	0.00292	CbGpPWpGaD
Ethinyl Estradiol—Pain in extremity—Doxorubicin—bone cancer	8.61e-05	0.00353	CcSEcCtD
Ethinyl Estradiol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	8.58e-05	0.0029	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	8.54e-05	0.00288	CbGpPWpGaD
Ethinyl Estradiol—Migraine—Doxorubicin—bone cancer	8.48e-05	0.00347	CcSEcCtD
Ethinyl Estradiol—Affect lability—Doxorubicin—bone cancer	8.48e-05	0.00347	CcSEcCtD
Ethinyl Estradiol—Methyltestosterone—CYP3A4—bone cancer	8.48e-05	0.0487	CrCbGaD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	8.46e-05	0.00286	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	8.45e-05	0.00285	CbGpPWpGaD
Ethinyl Estradiol—Breast disorder—Epirubicin—bone cancer	8.41e-05	0.00345	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—MMP2—bone cancer	8.3e-05	0.0028	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	8.23e-05	0.00278	CbGpPWpGaD
Ethinyl Estradiol—Mood swings—Doxorubicin—bone cancer	8.16e-05	0.00334	CcSEcCtD
Ethinyl Estradiol—Conjugated Estrogens—CYP3A4—bone cancer	8.11e-05	0.0466	CrCbGaD
Ethinyl Estradiol—Abdominal distension—Epirubicin—bone cancer	8.1e-05	0.00332	CcSEcCtD
Ethinyl Estradiol—Estrone—CYP3A4—bone cancer	8.09e-05	0.0464	CrCbGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—NR1I2—bone cancer	8.06e-05	0.00272	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—RB1—bone cancer	8.05e-05	0.00272	CbGpPWpGaD
Ethinyl Estradiol—Dysuria—Methotrexate—bone cancer	8.04e-05	0.00329	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—PLAU—bone cancer	8.02e-05	0.00271	CbGpPWpGaD
Ethinyl Estradiol—Upper respiratory tract infection—Methotrexate—bone cancer	7.99e-05	0.00327	CcSEcCtD
Ethinyl Estradiol—NR1I2—Gene Expression—FUS—bone cancer	7.95e-05	0.00268	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.92e-05	0.00267	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—NDUFA12—bone cancer	7.82e-05	0.00264	CbGpPWpGaD
Ethinyl Estradiol—Breast disorder—Doxorubicin—bone cancer	7.78e-05	0.00319	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Epirubicin—bone cancer	7.74e-05	0.00317	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Cisplatin—bone cancer	7.69e-05	0.00315	CcSEcCtD
Ethinyl Estradiol—Infestation—Methotrexate—bone cancer	7.67e-05	0.00314	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Methotrexate—bone cancer	7.67e-05	0.00314	CcSEcCtD
Ethinyl Estradiol—Depression—Methotrexate—bone cancer	7.64e-05	0.00313	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—CDK4—bone cancer	7.58e-05	0.00256	CbGpPWpGaD
Ethinyl Estradiol—Dysuria—Epirubicin—bone cancer	7.52e-05	0.00308	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Doxorubicin—bone cancer	7.49e-05	0.00307	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Epirubicin—bone cancer	7.48e-05	0.00306	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Epirubicin—bone cancer	7.43e-05	0.00305	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	7.42e-05	0.0025	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Cisplatin—bone cancer	7.34e-05	0.00301	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	7.33e-05	0.00247	CbGpPWpGaD
Ethinyl Estradiol—Weight increased—Epirubicin—bone cancer	7.32e-05	0.003	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Epirubicin—bone cancer	7.28e-05	0.00298	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	7.23e-05	0.00244	CbGpPWpGaD
Ethinyl Estradiol—Infestation NOS—Epirubicin—bone cancer	7.17e-05	0.00294	CcSEcCtD
Ethinyl Estradiol—Infestation—Epirubicin—bone cancer	7.17e-05	0.00294	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Doxorubicin—bone cancer	7.16e-05	0.00293	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Cisplatin—bone cancer	7.04e-05	0.00289	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Epirubicin—bone cancer	7.03e-05	0.00288	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.02e-05	0.00237	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—PLAU—bone cancer	7e-05	0.00236	CbGpPWpGaD
Ethinyl Estradiol—Urinary tract infection—Epirubicin—bone cancer	6.97e-05	0.00286	CcSEcCtD
Ethinyl Estradiol—Dysuria—Doxorubicin—bone cancer	6.96e-05	0.00285	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Doxorubicin—bone cancer	6.92e-05	0.00283	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Methotrexate—bone cancer	6.92e-05	0.00283	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Methotrexate—bone cancer	6.88e-05	0.00282	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Doxorubicin—bone cancer	6.88e-05	0.00282	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Methotrexate—bone cancer	6.83e-05	0.0028	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Methotrexate—bone cancer	6.8e-05	0.00278	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	6.78e-05	0.00229	CbGpPWpGaD
Ethinyl Estradiol—Weight increased—Doxorubicin—bone cancer	6.78e-05	0.00278	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Methotrexate—bone cancer	6.75e-05	0.00276	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Doxorubicin—bone cancer	6.74e-05	0.00276	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Epirubicin—bone cancer	6.73e-05	0.00276	CcSEcCtD
Ethinyl Estradiol—AOX1—Metabolism—NDUFA12—bone cancer	6.73e-05	0.00227	CbGpPWpGaD
Ethinyl Estradiol—Infestation—Doxorubicin—bone cancer	6.64e-05	0.00272	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Doxorubicin—bone cancer	6.64e-05	0.00272	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methotrexate—bone cancer	6.63e-05	0.00272	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	6.61e-05	0.00223	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—RB1—bone cancer	6.59e-05	0.00223	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Cisplatin—bone cancer	6.56e-05	0.00269	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Methotrexate—bone cancer	6.51e-05	0.00267	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Doxorubicin—bone cancer	6.51e-05	0.00267	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—NT5C3A—bone cancer	6.48e-05	0.00219	CbGpPWpGaD
Ethinyl Estradiol—Haemoglobin—Epirubicin—bone cancer	6.47e-05	0.00265	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Epirubicin—bone cancer	6.46e-05	0.00265	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Doxorubicin—bone cancer	6.45e-05	0.00264	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Epirubicin—bone cancer	6.44e-05	0.00264	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methotrexate—bone cancer	6.43e-05	0.00263	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Epirubicin—bone cancer	6.41e-05	0.00263	CcSEcCtD
Ethinyl Estradiol—Asthenia—Cisplatin—bone cancer	6.39e-05	0.00262	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Epirubicin—bone cancer	6.39e-05	0.00262	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	6.36e-05	0.00215	CbGpPWpGaD
Ethinyl Estradiol—Urinary tract disorder—Epirubicin—bone cancer	6.36e-05	0.00261	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Epirubicin—bone cancer	6.33e-05	0.00259	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—MMP2—bone cancer	6.32e-05	0.00213	CbGpPWpGaD
Ethinyl Estradiol—Urethral disorder—Epirubicin—bone cancer	6.31e-05	0.00259	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methotrexate—bone cancer	6.24e-05	0.00256	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Doxorubicin—bone cancer	6.23e-05	0.00255	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methotrexate—bone cancer	6.22e-05	0.00255	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Epirubicin—bone cancer	6.21e-05	0.00254	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXA1 transcription factor network—JUN—bone cancer	6.18e-05	0.00209	CbGpPWpGaD
Ethinyl Estradiol—Estradiol—CYP3A4—bone cancer	6.13e-05	0.0352	CrCbGaD
Ethinyl Estradiol—Diarrhoea—Cisplatin—bone cancer	6.1e-05	0.0025	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Epirubicin—bone cancer	6.09e-05	0.00249	CcSEcCtD
Ethinyl Estradiol—Alopecia—Methotrexate—bone cancer	6.08e-05	0.00249	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methotrexate—bone cancer	6.03e-05	0.00247	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Epirubicin—bone cancer	6.02e-05	0.00247	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methotrexate—bone cancer	5.99e-05	0.00245	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Doxorubicin—bone cancer	5.99e-05	0.00245	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Doxorubicin—bone cancer	5.97e-05	0.00245	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Doxorubicin—bone cancer	5.96e-05	0.00244	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	5.94e-05	0.00201	CbGpPWpGaD
Ethinyl Estradiol—Hypoaesthesia—Doxorubicin—bone cancer	5.93e-05	0.00243	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Doxorubicin—bone cancer	5.91e-05	0.00242	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—ATF1—bone cancer	5.91e-05	0.002	CbGpPWpGaD
Ethinyl Estradiol—Urinary tract disorder—Doxorubicin—bone cancer	5.88e-05	0.00241	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	5.88e-05	0.00199	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.87e-05	0.00198	CbGpPWpGaD
Ethinyl Estradiol—Connective tissue disorder—Doxorubicin—bone cancer	5.86e-05	0.0024	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Epirubicin—bone cancer	5.84e-05	0.00239	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Doxorubicin—bone cancer	5.84e-05	0.00239	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Epirubicin—bone cancer	5.82e-05	0.00238	CcSEcCtD
Ethinyl Estradiol—Back pain—Methotrexate—bone cancer	5.79e-05	0.00237	CcSEcCtD
Ethinyl Estradiol—ESR1—Gene Expression—ZNF77—bone cancer	5.78e-05	0.00195	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	5.76e-05	0.00195	CbGpPWpGaD
Ethinyl Estradiol—Visual impairment—Doxorubicin—bone cancer	5.74e-05	0.00235	CcSEcCtD
Ethinyl Estradiol—ABCC2—NRF2 pathway—GSTP1—bone cancer	5.7e-05	0.00192	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—NRF2 pathway—TGFBR2—bone cancer	5.7e-05	0.00192	CbGpPWpGaD
Ethinyl Estradiol—Alopecia—Epirubicin—bone cancer	5.69e-05	0.00233	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	5.69e-05	0.00192	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Cisplatin—bone cancer	5.66e-05	0.00232	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Epirubicin—bone cancer	5.64e-05	0.00231	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Doxorubicin—bone cancer	5.63e-05	0.00231	CcSEcCtD
Ethinyl Estradiol—Rash—Cisplatin—bone cancer	5.62e-05	0.0023	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Cisplatin—bone cancer	5.61e-05	0.0023	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Epirubicin—bone cancer	5.61e-05	0.0023	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—FUS—bone cancer	5.6e-05	0.00189	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—NT5C3A—bone cancer	5.57e-05	0.00188	CbGpPWpGaD
Ethinyl Estradiol—Eye disorder—Doxorubicin—bone cancer	5.57e-05	0.00228	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methotrexate—bone cancer	5.56e-05	0.00228	CcSEcCtD
Ethinyl Estradiol—Back pain—Epirubicin—bone cancer	5.42e-05	0.00222	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Doxorubicin—bone cancer	5.41e-05	0.00221	CcSEcCtD
Ethinyl Estradiol—Malaise—Methotrexate—bone cancer	5.4e-05	0.00221	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Epirubicin—bone cancer	5.39e-05	0.00221	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Doxorubicin—bone cancer	5.38e-05	0.00221	CcSEcCtD
Ethinyl Estradiol—Nausea—Cisplatin—bone cancer	5.29e-05	0.00217	CcSEcCtD
Ethinyl Estradiol—Alopecia—Doxorubicin—bone cancer	5.27e-05	0.00216	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.25e-05	0.00177	CbGpPWpGaD
Ethinyl Estradiol—Cough—Methotrexate—bone cancer	5.23e-05	0.00214	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Doxorubicin—bone cancer	5.22e-05	0.00214	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Epirubicin—bone cancer	5.2e-05	0.00213	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Doxorubicin—bone cancer	5.19e-05	0.00213	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	5.06e-05	0.00208	CcSEcCtD
Ethinyl Estradiol—Malaise—Epirubicin—bone cancer	5.06e-05	0.00207	CcSEcCtD
Ethinyl Estradiol—Discomfort—Methotrexate—bone cancer	5.04e-05	0.00206	CcSEcCtD
Ethinyl Estradiol—Back pain—Doxorubicin—bone cancer	5.02e-05	0.00206	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Doxorubicin—bone cancer	4.99e-05	0.00204	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	4.93e-05	0.00166	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	4.9e-05	0.00165	CbGpPWpGaD
Ethinyl Estradiol—Cough—Epirubicin—bone cancer	4.89e-05	0.002	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—JUN—bone cancer	4.89e-05	0.00165	CbGpPWpGaD
Ethinyl Estradiol—Infection—Methotrexate—bone cancer	4.86e-05	0.00199	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	4.82e-05	0.00163	CbGpPWpGaD
Ethinyl Estradiol—Ill-defined disorder—Doxorubicin—bone cancer	4.81e-05	0.00197	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Methotrexate—bone cancer	4.79e-05	0.00196	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.78e-05	0.00161	CbGpPWpGaD
Ethinyl Estradiol—Anxiety—Epirubicin—bone cancer	4.76e-05	0.00195	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methotrexate—bone cancer	4.75e-05	0.00195	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	4.74e-05	0.00194	CcSEcCtD
Ethinyl Estradiol—Discomfort—Epirubicin—bone cancer	4.72e-05	0.00193	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.71e-05	0.00159	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.69e-05	0.00158	CbGpPWpGaD
Ethinyl Estradiol—Malaise—Doxorubicin—bone cancer	4.68e-05	0.00192	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism—NDUFA12—bone cancer	4.61e-05	0.00156	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	4.58e-05	0.00155	CbGpPWpGaD
Ethinyl Estradiol—Oedema—Epirubicin—bone cancer	4.58e-05	0.00187	CcSEcCtD
Ethinyl Estradiol—Infection—Epirubicin—bone cancer	4.55e-05	0.00186	CcSEcCtD
Ethinyl Estradiol—Cough—Doxorubicin—bone cancer	4.53e-05	0.00185	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Epirubicin—bone cancer	4.49e-05	0.00184	CcSEcCtD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.48e-05	0.00151	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—JUN—bone cancer	4.45e-05	0.0015	CbGpPWpGaD
Ethinyl Estradiol—Skin disorder—Epirubicin—bone cancer	4.44e-05	0.00182	CcSEcCtD
Ethinyl Estradiol—Anxiety—Doxorubicin—bone cancer	4.4e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	4.39e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	4.38e-05	0.00148	CbGpPWpGaD
Ethinyl Estradiol—Discomfort—Doxorubicin—bone cancer	4.36e-05	0.00179	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—JUN—bone cancer	4.36e-05	0.00147	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.36e-05	0.00147	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—JUN—bone cancer	4.26e-05	0.00144	CbGpPWpGaD
Ethinyl Estradiol—Oedema—Doxorubicin—bone cancer	4.23e-05	0.00173	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Methotrexate—bone cancer	4.22e-05	0.00173	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methotrexate—bone cancer	4.22e-05	0.00173	CcSEcCtD
Ethinyl Estradiol—Infection—Doxorubicin—bone cancer	4.21e-05	0.00172	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.2e-05	0.00142	CbGpPWpGaD
Ethinyl Estradiol—ESR1—LKB1 signaling events—TP53—bone cancer	4.15e-05	0.0014	CbGpPWpGaD
Ethinyl Estradiol—Nervous system disorder—Doxorubicin—bone cancer	4.15e-05	0.0017	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—MMP9—bone cancer	4.15e-05	0.0014	CbGpPWpGaD
Ethinyl Estradiol—Skin disorder—Doxorubicin—bone cancer	4.11e-05	0.00168	CcSEcCtD
Ethinyl Estradiol—NR1I2—Gene Expression—EIF2S1—bone cancer	4.07e-05	0.00137	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—NR1I2—bone cancer	4.06e-05	0.00137	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Methotrexate—bone cancer	4.03e-05	0.00165	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methotrexate—bone cancer	4e-05	0.00164	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	3.99e-05	0.00135	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal disorder—Epirubicin—bone cancer	3.95e-05	0.00162	CcSEcCtD
Ethinyl Estradiol—Fatigue—Epirubicin—bone cancer	3.94e-05	0.00162	CcSEcCtD
Ethinyl Estradiol—Constipation—Epirubicin—bone cancer	3.91e-05	0.0016	CcSEcCtD
Ethinyl Estradiol—Urticaria—Methotrexate—bone cancer	3.88e-05	0.00159	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—NR1I2—bone cancer	3.88e-05	0.00131	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.87e-05	0.00131	CbGpPWpGaD
Ethinyl Estradiol—Body temperature increased—Methotrexate—bone cancer	3.86e-05	0.00158	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methotrexate—bone cancer	3.86e-05	0.00158	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism—NT5C3A—bone cancer	3.82e-05	0.00129	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	3.79e-05	0.00128	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.79e-05	0.00128	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Epirubicin—bone cancer	3.77e-05	0.00154	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	3.76e-05	0.00127	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal pain—Epirubicin—bone cancer	3.74e-05	0.00153	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Biological oxidations—CYP3A4—bone cancer	3.73e-05	0.00126	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	3.68e-05	0.00124	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal disorder—Doxorubicin—bone cancer	3.65e-05	0.0015	CcSEcCtD
Ethinyl Estradiol—Fatigue—Doxorubicin—bone cancer	3.65e-05	0.0015	CcSEcCtD
Ethinyl Estradiol—Urticaria—Epirubicin—bone cancer	3.63e-05	0.00149	CcSEcCtD
Ethinyl Estradiol—Constipation—Doxorubicin—bone cancer	3.62e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Epirubicin—bone cancer	3.62e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Epirubicin—bone cancer	3.62e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Methotrexate—bone cancer	3.6e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	3.59e-05	0.00121	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—CDK4—bone cancer	3.58e-05	0.00121	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—EZH2—bone cancer	3.54e-05	0.00119	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Methotrexate—bone cancer	3.51e-05	0.00144	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Doxorubicin—bone cancer	3.49e-05	0.00143	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Doxorubicin—bone cancer	3.46e-05	0.00142	CcSEcCtD
Ethinyl Estradiol—Pruritus—Methotrexate—bone cancer	3.46e-05	0.00142	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—EGFR—bone cancer	3.43e-05	0.00116	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Epirubicin—bone cancer	3.37e-05	0.00138	CcSEcCtD
Ethinyl Estradiol—Urticaria—Doxorubicin—bone cancer	3.36e-05	0.00138	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—KIT—bone cancer	3.35e-05	0.00113	CbGpPWpGaD
Ethinyl Estradiol—Abdominal pain—Doxorubicin—bone cancer	3.35e-05	0.00137	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Doxorubicin—bone cancer	3.35e-05	0.00137	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Methotrexate—bone cancer	3.35e-05	0.00137	CcSEcCtD
Ethinyl Estradiol—Asthenia—Epirubicin—bone cancer	3.28e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Pruritus—Epirubicin—bone cancer	3.24e-05	0.00133	CcSEcCtD
Ethinyl Estradiol—Dizziness—Methotrexate—bone cancer	3.23e-05	0.00132	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Biological oxidations—GSTP1—bone cancer	3.19e-05	0.00108	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—BRAF—bone cancer	3.16e-05	0.00107	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Biological oxidations—CYP3A4—bone cancer	3.16e-05	0.00107	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	3.14e-05	0.00106	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Epirubicin—bone cancer	3.13e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Doxorubicin—bone cancer	3.12e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	3.11e-05	0.00105	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—RB1—bone cancer	3.11e-05	0.00105	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Methotrexate—bone cancer	3.11e-05	0.00127	CcSEcCtD
Ethinyl Estradiol—Rash—Methotrexate—bone cancer	3.08e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methotrexate—bone cancer	3.08e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Headache—Methotrexate—bone cancer	3.06e-05	0.00125	CcSEcCtD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	3.05e-05	0.00103	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Doxorubicin—bone cancer	3.04e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Dizziness—Epirubicin—bone cancer	3.03e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Pruritus—Doxorubicin—bone cancer	3e-05	0.00123	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.98e-05	0.001	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.96e-05	0.001	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—ENO2—bone cancer	2.92e-05	0.000984	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Epirubicin—bone cancer	2.91e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Nausea—Methotrexate—bone cancer	2.9e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Doxorubicin—bone cancer	2.9e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Rash—Epirubicin—bone cancer	2.88e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Epirubicin—bone cancer	2.88e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Headache—Epirubicin—bone cancer	2.87e-05	0.00117	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—EIF2S1—bone cancer	2.87e-05	0.000967	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—ENO2—bone cancer	2.84e-05	0.000958	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—FUS—bone cancer	2.82e-05	0.000953	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—TP53—bone cancer	2.81e-05	0.000949	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Doxorubicin—bone cancer	2.8e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	2.78e-05	0.000937	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Epirubicin—bone cancer	2.72e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—AOX1—Disease—DHFR—bone cancer	2.7e-05	0.000913	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Biological oxidations—GSTP1—bone cancer	2.7e-05	0.000911	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Doxorubicin—bone cancer	2.69e-05	0.0011	CcSEcCtD
Ethinyl Estradiol—Rash—Doxorubicin—bone cancer	2.67e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Doxorubicin—bone cancer	2.67e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	2.66e-05	0.000898	CbGpPWpGaD
Ethinyl Estradiol—Headache—Doxorubicin—bone cancer	2.65e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	2.65e-05	0.000895	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—MDM2—bone cancer	2.64e-05	0.00089	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—DHFR—bone cancer	2.63e-05	0.000889	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	2.53e-05	0.000853	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Doxorubicin—bone cancer	2.51e-05	0.00103	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.5e-05	0.000844	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	2.49e-05	0.000842	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—EZH2—bone cancer	2.49e-05	0.00084	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—GNA11—bone cancer	2.46e-05	0.000831	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ENO2—bone cancer	2.44e-05	0.000824	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	2.36e-05	0.000798	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	2.3e-05	0.000778	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—DHFR—bone cancer	2.27e-05	0.000765	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	2.24e-05	0.000755	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NDUFA12—bone cancer	2.23e-05	0.000754	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—CYP3A4—bone cancer	2.23e-05	0.000753	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.22e-05	0.00075	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.2e-05	0.000741	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.12e-05	0.000715	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—GNA11—bone cancer	2.12e-05	0.000715	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	2.11e-05	0.000713	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.11e-05	0.000711	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—TGFBR2—bone cancer	1.96e-05	0.000662	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—NR1I2—bone cancer	1.96e-05	0.00066	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—CYP3A4—bone cancer	1.92e-05	0.000648	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—GSTP1—bone cancer	1.91e-05	0.000644	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.91e-05	0.000644	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NDUFA12—bone cancer	1.89e-05	0.000638	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NT5C3A—bone cancer	1.85e-05	0.000625	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.82e-05	0.000614	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.81e-05	0.000611	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—EGFR—bone cancer	1.8e-05	0.000608	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ENO2—bone cancer	1.67e-05	0.000565	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NDUFA12—bone cancer	1.65e-05	0.000556	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—GSTP1—bone cancer	1.64e-05	0.000554	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.57e-05	0.000529	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NT5C3A—bone cancer	1.57e-05	0.000529	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—DHFR—bone cancer	1.55e-05	0.000524	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	1.52e-05	0.000513	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.5e-05	0.000507	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GRM4—bone cancer	1.47e-05	0.000495	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—RGS1—bone cancer	1.47e-05	0.000495	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GNA11—bone cancer	1.45e-05	0.00049	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.45e-05	0.000489	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—EIF2S1—bone cancer	1.44e-05	0.000488	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.43e-05	0.000482	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NT5C3A—bone cancer	1.37e-05	0.000461	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—KIT—bone cancer	1.34e-05	0.000451	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CYP3A4—bone cancer	1.32e-05	0.000444	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.31e-05	0.000442	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GRM1—bone cancer	1.27e-05	0.000429	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.26e-05	0.000425	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—BRAF—bone cancer	1.26e-05	0.000424	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—EZH2—bone cancer	1.25e-05	0.000424	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.16e-05	0.000392	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GSTP1—bone cancer	1.13e-05	0.00038	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.12e-05	0.000378	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MDM2—bone cancer	1.05e-05	0.000356	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PTGS2—bone cancer	1.02e-05	0.000343	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NDUFA12—bone cancer	1.02e-05	0.000343	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.01e-05	0.000341	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PTGS2—bone cancer	9.89e-06	0.000334	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SMO—bone cancer	8.96e-06	0.000302	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTGS2—bone cancer	8.5e-06	0.000287	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NT5C3A—bone cancer	8.41e-06	0.000284	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GNA11—bone cancer	8.2e-06	0.000277	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ENO2—bone cancer	8.11e-06	0.000274	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	7.94e-06	0.000268	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ATF1—bone cancer	7.62e-06	0.000257	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—DHFR—bone cancer	7.52e-06	0.000254	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL3—bone cancer	7.43e-06	0.000251	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—EGFR—bone cancer	7.2e-06	0.000243	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GNA11—bone cancer	7.03e-06	0.000237	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ENO2—bone cancer	6.87e-06	0.000232	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	6.67e-06	0.000225	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP3A4—bone cancer	6.37e-06	0.000215	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—DHFR—bone cancer	6.37e-06	0.000215	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TGFBR2—bone cancer	6.35e-06	0.000215	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ENO2—bone cancer	5.98e-06	0.000202	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IGF1R—bone cancer	5.98e-06	0.000202	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GNA11—bone cancer	5.95e-06	0.000201	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTGS2—bone cancer	5.83e-06	0.000197	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—DHFR—bone cancer	5.55e-06	0.000187	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTP1—bone cancer	5.45e-06	0.000184	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP3A4—bone cancer	5.4e-06	0.000182	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.37e-06	0.000181	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GNA11—bone cancer	5.19e-06	0.000175	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP3A4—bone cancer	4.7e-06	0.000159	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTP1—bone cancer	4.62e-06	0.000156	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KIT—bone cancer	4.34e-06	0.000146	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—BRAF—bone cancer	4.08e-06	0.000138	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTP1—bone cancer	4.02e-06	0.000136	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ENO2—bone cancer	3.69e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—DHFR—bone cancer	3.42e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MDM2—bone cancer	3.42e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GNA11—bone cancer	3.2e-06	0.000108	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—JUN—bone cancer	2.97e-06	0.0001	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MMP9—bone cancer	2.89e-06	9.75e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTGS2—bone cancer	2.82e-06	9.53e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTP1—bone cancer	2.48e-06	8.36e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTGS2—bone cancer	2.39e-06	8.07e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EGFR—bone cancer	2.33e-06	7.88e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTGS2—bone cancer	2.08e-06	7.03e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—bone cancer	1.96e-06	6.61e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTGS2—bone cancer	1.28e-06	4.33e-05	CbGpPWpGaD
